WORMCON: A Multinational Trial of the Efficacy of Albendazole Against Soil-transmitted Nematode Infections in Children

Sponsor
University Ghent (Other)
Overall Status
Completed
CT.gov ID
NCT01087099
Collaborator
World Health Organization (Other), George Washington University (Other), Commonwealth Scientific and Industrial Research Organisation, Division of Livestock Industries, Brisbane, Australia (Other), University of Nottingham (Other), Queensland Institute of Medical Research (Other)
1,750
7
1
13.9
250
17.9

Study Details

Study Description

Brief Summary

The three major Soil-Transmitted Helminths (STH), Ascaris lumbricoides, Necator americanus/Ancylostoma duodenal and Trichuris trichiura are among the most prevalent parasites worldwide. The objective of this multicentre international study is to define the efficacy of a single 400 milligram dose of albendazole (ALB) against these three STHs using a standardised protocol. The trial will be undertaken among school age children in seven countries - Brazil, Cameroon, Cambodia, Ethiopia, India, Tanzania (Zanzibar) and Vietnam - each with a different epidemiologic pattern of infection. A trial of this nature is urgently required because in spite of the wide usage of albendazole over the last 3 decades, there is still no key publication reporting the efficacy of the anthelmintic accurately, and to modern conventional standards, that can act as a central reference for the baseline efficacy. The latter is critically important because albendazole is now being used even more widely, as large scale mass treatment campaigns are being implemented in Africa and elsewhere, with the intention of reducing morbidity in children. Such large scale usage of a drug risks resistance developing, but resistance cannot be detected unless benchmark values for baseline efficacy are widely known.

Condition or Disease Intervention/Treatment Phase
Phase 4

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1750 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Multinational Trial of the Efficacy of Albendazole Against Soil-transmitted Nematode Infections in Children
Study Start Date :
Jan 1, 2009
Actual Primary Completion Date :
Dec 1, 2009
Actual Study Completion Date :
Mar 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Experimental: Albendazole

Treatment with albendazole

Drug: Albendazole
Treatment with albendazole

Outcome Measures

Primary Outcome Measures

  1. Efficacy of albendazole [14 to 30 days after treatment]

    To determine the efficacy of albendazole, and this will be assessed by the reduction in parasite faecal egg counts between the pre- and post-intervention surveys. The latter will be conducted 14-30 days after treatment.

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 14 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children should be infected with a minimum of 150 eggs/gram of any of the three species of STH (i.e. Ascaris or hookworms or Trichuris).
Exclusion Criteria:
  • Not willing to participate

  • Unable to give samples for follow up

  • Severe intercurrent medical condition

  • Diarrhoea at first sampling

Contacts and Locations

Locations

Site City State Country Postal Code
1 Instituto René Rachou, Fundação Oswaldo Cruz Minas Gerais Brazil
2 Institut Pasteur in Cambodia, Clinical Pathology Unit Phnom Penh Cambodia
3 Centre for Schistosomiasis and Parasitology, Faculty of Sciences, University of Yaoundé I Yaounde Cameroon
4 Department of Medical Laboratory Sciences and Pathology , College of Public Health and Medical Sciences, Jimma University Jimma, Ethiopia
5 Department of Gastrointestinal Sciences, Christian Medical College Vellore India
6 Public Health Laboratory Zanzibar Tanzania
7 National Institute for Malariology, Parasitology and Entomology Hanoi Vietnam

Sponsors and Collaborators

  • University Ghent
  • World Health Organization
  • George Washington University
  • Commonwealth Scientific and Industrial Research Organisation, Division of Livestock Industries, Brisbane, Australia
  • University of Nottingham
  • Queensland Institute of Medical Research

Investigators

  • Principal Investigator: Jozef Vercruysse, University Ghent

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT01087099
Other Study ID Numbers:
  • 2008/322
First Posted:
Mar 15, 2010
Last Update Posted:
Aug 2, 2011
Last Verified:
Jul 1, 2011

Study Results

No Results Posted as of Aug 2, 2011